Search
for
Sort by
Research 121–150 of 1000+
- Skin diseases in consequence of endocrine alterations
- Urinary steroids in women with androgenic alopecia
- Alopecia and Hirsuties
- Hirsutism in the Adolescent Female
- Clinical review 74: Dermatological manifestations of endocrine disorders.
- “Osler’s phenomenon”: misdiagnosing Cushing’s syndrome
- Treatment of androgen excess in females: Yesterday, today and tomorrow
- Effects of <i>In Utero</i> Exposure to D-004, a Lipid Extract from <i>Roystonea regia</i> Fruits, in the Male Rat: A Comparison with Finasteride
- Biology of the skin and dermatological disease
- Challenges in treatment of patients with non-classic congenital adrenal hyperplasia
- Utilisation of gonadotrophin-releasing hormone (GnRH) analogue to differentiate ovarian from adrenal hyperandrogenism in postmenopausal women
- Severe impact of late diagnosis of congenital adrenal hyperplasia on gender identity, sexual orientation and function: case report and review of the literature
- Hyperandrogenic eumenorrheic NON-PCOS women versus women with PCOS after the GnRH-agonist stimulation test preceded by suppression of adrenal steroidogenesis with dexamethasone
- Aldosterone- and cortisol-cosecreting adrenal adenoma, ovarian hyperthecosis and breast cancer
- Adult Acne
- Androgen replacement therapy in women
- The Case of the Elusive Androgen
- Testosterone Therapy in Women: A Literature Review of Clinical Indications, Dosing, Routes of Administration, and Safety
- Delayed Diagnosis of Congenital Adrenal Hyperplasia Due to 3β-Hydroxysteroid Dehydrogenase Type 2 Deficiency
- Androgen excess: a hallmark of polycystic ovary syndrome
- Clinical analysis of 78 patients with non-classical 21-hydroxylase deficiency
- Alopecia: managing the basics
- Hiperandrogenismo tras la menopausia
- Faculty Opinions recommendation of Effects of dehydroepiandrosterone therapy on pubic hair growth and psychological well-being in adolescent girls and young women with central adrenal insufficiency: a double-blind, randomized, placebo-controlled phase III trial.
- Registrars’ Symposium: Summaries of Papers
- Biological Profile of Cortexolone 17a-Propionate (CB-03-01), a New Topical and Peripherally Selective Androgen Antagonist
- Diagnosis and treatments of hirsutism: where are we?
- Metabolic dysfunction in female mice with disruption of 5α-reductase 1
- Ovarian and Adrenal Venous Catheterization for Hyperandrogenism
- Animal models of androgen-dependent disorders of the pilosebaceous apparatus